Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious... Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. Mehr anzeigen
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on October 31, 2024...
IM-1021 showed superior potency when compared to a competitor in both mantle cell lymphoma and triple-negative breast cancer preclinical models; IND submission expected in 1Q25 HC74, Immunome’s...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that it will present a poster highlighting...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on the development of first-in-class and best-in-class targeted oncology therapies, today announced the appointment of Roee Shahar...
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on October 3, 2024...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.47 | 3.80875202593 | 12.34 | 12.82 | 11.43 | 414438 | 11.86907144 | CS |
| 4 | -0.42 | -3.1746031746 | 13.23 | 13.4 | 11.33 | 553860 | 12.09993168 | CS |
| 12 | -0.19 | -1.46153846154 | 13 | 16.73 | 11.33 | 613401 | 13.8247119 | CS |
| 26 | -2.94 | -18.6666666667 | 15.75 | 16.81 | 11.07 | 713744 | 13.8895267 | CS |
| 52 | 4.21 | 48.9534883721 | 8.6 | 30.958 | 6.93 | 644092 | 16.08667535 | CS |
| 156 | -9.54 | -42.6845637584 | 22.35 | 30.958 | 2.09 | 266920 | 14.33898225 | CS |
| 260 | -2.85 | -18.1992337165 | 15.66 | 63.78 | 2.09 | 254691 | 16.38177891 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
